17 Juin 2013
Early HPV testing could detect sexually-transmitted oral cancer
Antibodies to a high-risk type of human papillomavirus (HPV16) could help detect oropharyngeal cancer several years before the clinical onset of the disease, reveals a new study from the International Agency for Research on Cancer (IARC) in cooperation with the German Cancer Research Center (DKFZ) and the United States National Cancer Institute (NCI) in an article published online today by the
Journal of Clinical Oncology.
A R Kreimer, M Johansson, T Waterboer, R Kaaks, J Chang-Claude, D Drogen, A Tjønneland et al.
Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer
Journal of Clinical Oncology published online on June 17, 2013; DOI: 10.1200/JCO.2012.47.2738
Read IARC Press Release 219Read article
IARC and the National Cancer Institute of Brazil launch a regional Learning Centre
The International Agency for Research on Cancer (IARC) and the National Cancer Institute of Brazi...
16.05.2024
Read more
Egypt joins the International Agency for Research on Cancer
The International Agency for Research on Cancer (IARC) is pleased to welcome Egypt as its 29th Pa...
15.05.2024
Read more
Kingdom of Saudi Arabia joins International Agency for Research on Cancer
The International Agency for Research on Cancer (IARC) today welcomes the Kingdom of Saudi Arabia...
15.05.2024
Read more